Cite

HARVARD Citation

    Janikashvili, N. et al. (2021). Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect. Oncoimmunology. p. . [Online]. 
  
Back to record